Literature DB >> 33469110

A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators.

Zhenjun Yu1, Yu Zhang1, Yingying Cao1, Manman Xu2, Shaoli You3, Yu Chen2, Bing Zhu3, Ming Kong2, Fangjiao Song3, Shaojie Xin4, Zhongping Duan5, Tao Han6,7,8.   

Abstract

Acute-on-chronic liver failure (ACLF) is a dynamic syndrome, and sequential assessments can reflect its prognosis more accurately. Our aim was to build and validate a new scoring system to predict short-term prognosis using baseline and dynamic data in ACLF. We conducted a retrospective cohort analysis of patients with ACLF from three different hospitals in China. To construct the model, we analyzed a training set of 541 patients from two hospitals. The model's performance was evaluated in a validation set of 130 patients from another center. In the training set, multivariate Cox regression analysis revealed that age, WGO type, basic etiology, total bilirubin, creatinine, prothrombin activity, and hepatic encephalopathy stage were all independent prognostic factors in ACLF. We designed a dynamic trend score table based on the changing trends of these indicators. Furthermore, a logistic prediction model (DP-ACLF) was constructed by combining the sum of dynamic trend scores and baseline prognostic parameters. All prognostic scores were calculated based on the clinical data of patients at the third day, first week, and second week after admission, respectively, and were correlated with the 90-day prognosis by ROC analysis. Comparative analysis showed that the AUC value for DP-ACLF was higher than for other prognostic scores, including Child-Turcotte-Pugh, MELD, MELD-Na, CLIF-SOFA, CLIF-C ACLF, and COSSH-ACLF. The new scoring model, which combined baseline characteristics and dynamic changes in clinical indicators to predict the course of ACLF, showed a better prognostic ability than current scoring systems. Prospective studies are needed to validate these results.

Entities:  

Year:  2021        PMID: 33469110      PMCID: PMC7815739          DOI: 10.1038/s41598-021-81431-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

1.  Evidence-based incorporation of serum sodium concentration into MELD.

Authors:  Scott W Biggins; W Ray Kim; Norah A Terrault; Sammy Saab; Vijay Balan; Thomas Schiano; Joanne Benson; Terry Therneau; Walter Kremers; Russell Wiesner; Patrick Kamath; Goran Klintmalm
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

2.  Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

Authors:  Andreas Kribben; Guido Gerken; Sebastian Haag; Stefan Herget-Rosenthal; Ulrich Treichel; Christoph Betz; Christoph Sarrazin; Eric Hoste; Hans Van Vlierberghe; Angels Escorsell; Carsten Hafer; Oliver Schreiner; Peter R Galle; Elena Mancini; Paolo Caraceni; Constantine J Karvellas; Hermann Salmhofer; Mladen Knotek; Pere Ginès; Justyna Kozik-Jaromin; Kinan Rifai
Journal:  Gastroenterology       Date:  2012-01-13       Impact factor: 22.682

3.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

4.  Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Scott W Biggins; Heather Patton; Michael B Fallon; Guadalupe Garcia-Tsao; Benedict Maliakkal; Raza Malik; Ram M Subramanian; Leroy R Thacker; Patrick S Kamath
Journal:  Hepatology       Date:  2014-05-29       Impact factor: 17.425

Review 5.  Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?

Authors:  Jasmohan S Bajaj; Richard Moreau; Patrick S Kamath; Hugo E Vargas; Vicente Arroyo; K Rajender Reddy; Gyongyi Szabo; Puneeta Tandon; Jody Olson; Constantine Karvellas; Thierry Gustot; Jennifer C Lai; Florence Wong
Journal:  Hepatology       Date:  2018-09-22       Impact factor: 17.425

Review 6.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials.

Authors:  Fayez Alshamsi; Khalil Alshammari; Emilie Belley-Cote; Joanna Dionne; Talal Albrahim; Budoor Albudoor; Mona Ismail; Bandar Al-Judaibi; Bandar Baw; Ram M Subramanian; Randolph Steadman; Dragos Galusca; David T Huang; Rahul Nanchal; Mustafa Al Quraini; Yuhong Yuan; Waleed Alhazzani
Journal:  Intensive Care Med       Date:  2019-10-07       Impact factor: 17.440

Review 8.  Considerations for Prognosis, Goals of Care, and Specialty Palliative Care for Hospitalized Patients With Acute-on-Chronic Liver Failure.

Authors:  Ruben Hernaez; Arpan Patel; Leanne K Jackson; Ursula K Braun; Anne M Walling; Hugo R Rosen
Journal:  Hepatology       Date:  2020-09       Impact factor: 17.425

Review 9.  Acute-on-chronic liver failure: terminology, mechanisms and management.

Authors:  Shiv K Sarin; Ashok Choudhury
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-03       Impact factor: 46.802

10.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.

Authors:  Rajiv Jalan; Faouzi Saliba; Marco Pavesi; Alex Amoros; Richard Moreau; Pere Ginès; Eric Levesque; Francois Durand; Paolo Angeli; Paolo Caraceni; Corinna Hopf; Carlo Alessandria; Ezequiel Rodriguez; Pablo Solis-Muñoz; Wim Laleman; Jonel Trebicka; Stefan Zeuzem; Thierry Gustot; Rajeshwar Mookerjee; Laure Elkrief; German Soriano; Joan Cordoba; Filippo Morando; Alexander Gerbes; Banwari Agarwal; Didier Samuel; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2014-06-17       Impact factor: 25.083

View more
  1 in total

1.  Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure.

Authors:  Xiufeng Wang; Yunqing Zhong; Rongzhen Zhang; Yueqiao Chen; Minggang Wang; Chao Lv; Dewen Mao
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-30       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.